The FDA and CBD-Infused Products: Understanding the Rules of the Road
Presented By: DRI
Since the legalization of hemp, we have seen explosive growth in hemp production, specifically the production of hemp-derived CBD products (e.g., food, beverages, topicals, dietary supplements, cosmetics and much more). However, the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), states and localities, and plaintiff’s attorneys have not been shy about going after products in this space. In this exciting and interactive session, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current CBD regulatory and litigation landscape and how they might change.
Who Should Attend:
What Will You Learn?: